US Broker Ratings

Tectonic Therapeutic, Inc. (TECX) Stock Analysis: Exploring a 304% Potential Upside in Biotech Innovation

For investors with an eye for biotechnology, Tectonic Therapeutic, Inc. (NASDAQ: TECX) offers a compelling opportunity. With a focus on innovative therapies targeting G protein-coupled receptors..

Kura Oncology, Inc. (KURA) Stock Analysis: Unveiling a 215% Potential Upside for Bold Investors

Kura Oncology, Inc. (NASDAQ: KURA), a promising player in the biotechnology sector, has been capturing the attention of investors with its compelling potential upside and strategic..

Upstream Bio, Inc. (UPB) Stock Analysis: A Biotech with 71% Potential Upside Worth Watching

Upstream Bio, Inc. (NASDAQ: UPB), a clinical-stage biotechnology firm focused on developing innovative treatments for inflammatory diseases, particularly severe respiratory disorders, is drawing significant attention from..

Precigen, Inc. (PGEN) Stock Analysis: Exploring a 134% Potential Upside in Biotech Innovations

Precigen, Inc. (NASDAQ: PGEN), a dynamic player in the biotechnology sector, is capturing investor attention with its pioneering gene and cell therapies. With a robust market..

Stoke Therapeutics, Inc. (STOK) Stock Analysis: A Biotech Contender with a 117% Revenue Growth Surge

Stoke Therapeutics, Inc. (NASDAQ: STOK), a biotechnology company specializing in the development of treatments for severe genetic disorders, has been gaining attention in the healthcare sector...

REGENXBIO Inc. (RGNX) Stock Analysis: A Promising Biotech with 129.93% Potential Upside

REGENXBIO Inc. (NASDAQ: RGNX) captures the attention of investors with its innovative gene therapy solutions and a significant potential upside. With a market capitalization of $650.51..

Cullinan Therapeutics, Inc. (CGEM) Stock Analysis: Unpacking the 134.88% Potential Upside

For investors with an eye on the biotechnology sector, Cullinan Therapeutics, Inc. (NASDAQ: CGEM) presents a compelling opportunity. This clinical-stage biopharmaceutical company, headquartered in Cambridge, Massachusetts,..

Bicycle Therapeutics plc (BCYC) Stock Analysis: A Biotech with a 189% Potential Upside

Bicycle Therapeutics plc (NASDAQ: BCYC) stands out in the biotechnology sector with its innovative approach to developing therapeutics for diseases underserved by current treatments. Based in..

Intellia Therapeutics, Inc. (NTLA): Investor Outlook Reveals 134.89% Potential Upside in Gene Editing Pioneer

Intellia Therapeutics, Inc. (NTLA), a trailblazer in the field of gene editing, is capturing investor attention with a remarkable potential upside of 134.89%. This biotechnology company..

SIGA Technologies Inc. (SIGA) Investor Outlook: Examining the Stock’s Growth Potential and Valuation Insights

SIGA Technologies Inc. (NASDAQ: SIGA), a commercial-stage pharmaceutical company headquartered in New York, focuses primarily on the health security market in the United States. Known for..

AxoGen, Inc. (AXGN) Stock Analysis: 15.63% Potential Upside Captivates Investors

AxoGen, Inc. (AXGN), a key player in the medical devices sector, continues to capture investor attention with its innovative approach to peripheral nerve regeneration and repair...

Rocket Pharmaceuticals, Inc. (RCKT) Stock Analysis: Unpacking a 130% Potential Upside in the Biotech Sector

Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT) is making waves in the biotechnology sector with its focus on developing groundbreaking gene therapies for rare and life-threatening diseases. With..

RxSight, Inc. (RXST) Stock Analysis: Examining the Market’s Reaction to the Innovative Medical Device Firm

RxSight, Inc. (NASDAQ: RXST), a promising player in the healthcare sector, specifically in the medical devices industry, has been making waves with its cutting-edge technology in..

Maze Therapeutics, Inc. (MAZE) Stock Analysis: Navigating a 9.3% Potential Upside Amid Biotech Innovations

Maze Therapeutics, Inc. (NASDAQ: MAZE), a dynamic player in the biotechnology sector, is capturing investor attention with its promising pipeline of precision medicines. Based in South..

Cel-Sci Corporation (CVM) Stock Analysis: A Biotech Pioneer with a 555% Upside Potential

Cel-Sci Corporation (NASDAQ: CVM) is a clinical-stage biotechnology firm that has captured the attention of investors with its ambitious approach to leveraging the immune system in..

Taysha Gene Therapies, Inc. (TSHA) Stock Analysis: Exploring a Promising 83.53% Upside in the Biotech Sector

Taysha Gene Therapies, Inc. (TSHA), a pioneering name in the biotechnology industry, commands attention with its potential upside of 83.53%, making it a compelling consideration for..

Owens & Minor, Inc. (OMI): A Healthcare Stock with Nearly 93% Potential Upside – Investor Outlook

Owens & Minor, Inc. (NYSE: OMI), with its rich history dating back to 1882, operates at the heart of the healthcare sector, specifically within the medical..

Community Health Systems, Inc. (CYH) Investor Outlook: Exploring a 19.12% Potential Upside

Community Health Systems, Inc. (NYSE: CYH) is positioned in a dynamic segment of the healthcare sector—medical care facilities—making it a notable consideration for investors focused on..

Mind Medicine (MindMed) Inc. (MNMD): Analyst Ratings Signal a 103% Upside Potential

Mind Medicine (MindMed) Inc. (NASDAQ: MNMD), a pioneering force in the biotechnology sector, is making waves with its promising outlook in the treatment of brain health..

Definitive Healthcare Corp. (DH) Stock Analysis: Can a 75% Upside Propel This Healthcare SaaS Provider Forward?

For investors keeping a keen eye on the healthcare information services sector, Definitive Healthcare Corp. (NASDAQ: DH) offers an intriguing proposition. The company, based in Framingham,..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds